NIST Publishes Assessment Procedures for Enhanced Security Controls Used to Protect CUI
Client Alert | 1 min read | 03.18.22
The National Institute of Standards and Technology (NIST) recently published final assessment procedures for the enhanced security controls used to protect particularly sensitive forms of controlled unclassified information (CUI) from sophisticated adversaries. NIST SP 800-172A, Assessing Enhanced Security Requirements for Controlled Unclassified Information, articulates procedures and methods to assess contractor implementation of the 35 enhanced security controls found in NIST SP 800-172, Enhanced Security Requirements for Protecting Controlled Unclassified Information: A Supplement to NIST Special Publication 800-171. The publication can be used to conduct first, second, and third-party assessments with varying degrees of rigor based on the assessor’s desired level of assurance.
The enhanced controls and corresponding assessment procedures are expected to impact contractors handling CUI associated with critical programs and high value assets. The Department of Defense (DoD) also plans to incorporate the requirements from NIST SP 800-172 into Level 3 of the Cybersecurity Maturity Model Certification (CMMC) The assessment procedures and methods in NIST SP 800-172A are expected to inform the government-led assessments needed for DoD contractors to achieve certification at CMMC Level 3.
Contacts

Partner and Crowell Global Advisors Senior Director
- Washington, D.C.
- D | +1.202.624.2698
- Washington, D.C. (CGA)
- D | +1 202.624.2500
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief

